Skip to content
Welcome, thoughtbot's Giant Robots listeners!Start here
UK Startups and Innovation
22OCT

Innovate UK opens £15m drone competitions

3 min read
16:30UTC

Innovate UK opened two defence-adjacent competitions on 5 May with a 3 June deadline: Counter UAS Technologies at up to £5m and Dual-Use Aviation Systems and Autonomy at up to £10m.

TechnologyDeveloping
Key takeaway

Innovate UK becomes the only UK defence-tech instrument writing confirmed cheques before June.

Innovate UK opened two defence-adjacent grant competitions on 5 May with a 3 June deadline: Counter UAS Technologies at up to £5m total with individual grants of £300,000 to £1.25m, and Dual-Use Aviation Systems and Autonomy at up to £10m⁠1. Both require SME-led collaboration. The Counter UAS competition covers detection, tracking and defeat of uncrewed aerial systems; Dual-Use Aviation covers civil-military aviation and autonomy. £15m of fresh defence-tech grant funding at the SME tier in a single window.

The Counter UAS and Dual-Use Aviation grants sit alongside the MoD's Sprint private-investment leverage mechanism and Zig-Zag secondment programme, both made permanent by Healey and Reeves in April, and the £20m accelerated contracts fund for startups with no prior MOD experience. Sprint and Zig-Zag have yet to publish a first deployment six weeks into operation. Innovate UK is therefore the only UK defence-tech instrument with a confirmed cheque schedule between now and June, and the grant range gives it a tighter fit with companies that cannot yet absorb a procurement contract.

The other context is the wider UK grant-award count, which fell to a 10-year low in 2025 even as the average grant size rose to £423,000. Counter UAS and Dual-Use Aviation are evidence that Innovate UK's DARPA-style portfolio model is now writing larger, fewer cheques into politically prioritised sectors. CircuitHub's $28m round (event index 10) sits adjacent to the same SME pipeline: contract electronics manufacturing for self-driving, satellite and defence hardware is exactly the supplier base the Counter UAS competition assumes exists.

Deep Analysis

In plain English

Innovate UK is the UK government agency that gives grants to companies developing new technologies. This week it opened two competitions specifically for defence-related technology with a 3 June deadline. The first, Counter UAS (Unmanned Aerial Systems), is about technology that can detect and stop drones; something that has become critically important after watching drone warfare in Ukraine. The second targets aviation systems built for both civilian and military use, focusing on autonomy and pilotless aircraft technology. Together these competitions offer £15m in grants to small and medium-sized businesses. The requirement that companies must work together in teams rather than applying alone is designed to build connections between small specialists who might be working on complementary pieces of the same problem.

Deep Analysis
Root Causes

The dual competition structure (Counter UAS at £5m, Dual-Use Aviation at £10m) reflects two distinct supply-chain gaps in the UK's defence SME base.

Counter UAS requires detection, tracking and defeat capabilities that are inherently dual-use: airport security, critical infrastructure protection and military applications overlap. UK SMEs in this space include Drone Defence and Blighter, but the competition is designed to expand the pool rather than re-fund existing players. The mandatory SME collaboration requirement is a gating mechanism to prevent large primes from capturing the small grants.

Dual-Use Aviation at £10m is a larger envelope targeting autonomy systems where the UK has competitive research programmes at Bristol, Cranfield and BAE's Advanced Air Mobility team, but limited commercial spinout history. The competition is effectively a first-use-case creation exercise for autonomy technologies that have been in university labs for years.

What could happen next?
  • Risk

    Sprint and Zig-Zag mechanisms launched six weeks ago have not published a first deployment; if the 3 June Counter UAS deadline produces winning consortia before Sprint has a working procurement pathway, the grants create pipeline without purchase commitments.

  • Opportunity

    Counter UAS grant winners with demonstrable field-deployment capability are positioned for the first Sprint leverage deployment, if DIAG targets the counter-drone pipeline as its first public case study.

First Reported In

Update #5 · State capital splits, allied money fills gap

MassDevice· 21 May 2026
Read original →
Different Perspectives
Abu Dhabi Investment Council
Abu Dhabi Investment Council
The Abu Dhabi Investment Council holds notes in Nscale's $3.36bn pre-IPO raise, beside Third Point, Apollo, Citadel and Nvidia. No British institution appears among the named holders of notes that convert into shares at Nscale's New York listing.
CDP Venture Capital
CDP Venture Capital
CDP Venture Capital, the venture arm of Italy's state lender, led TrueLayer's £20.4m round to expand Pay by Bank across Europe. A foreign state investor set the terms on a London fintech round in the same month the British Business Bank mostly followed.
EDBI
EDBI
Singapore's state investor EDBI joined Universal Quantum's Series A of more than $100m, and the Sussex company is opening its first research centre outside Europe in Singapore. British state money is absent from the largest Series A by a UK quantum company.
Forbion
Forbion
Forbion co-led OMass Therapeutics' $310m Series C with Bain Capital Life Sciences and Novo Holdings, while the British Business Bank and Syncona followed. The terms of the Oxford spinout's round were set by investors from three countries, none of them Britain.
British Business Bank
British Business Bank
The Bank committed £180m to six AI funds on 15 October with no UK-deployment condition, yet led the first close of Microbiotica's £36m Series C. That lead, with Airtel Money choosing London for its £5.3bn debut, is the evidence that British money and markets still set some terms.
Stryker Corporation
Stryker Corporation
Stryker called its roughly $400m CMR Surgical deal its entry into soft-tissue robotics, taking US sales rights for Versius, a board seat and an exclusive option over 100% of the company. The option lets Stryker choose whether and when a Cambridge robot maker becomes part of an American group.

Written with AI from Lowdown's published reporting. Not individually reviewed by an editor. Editorial standards.